HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of anti-platelet antibodies in dogs naturally co-infected by Leishmania infantum and Ehrlichia canis.

Abstract
Thirty naturally infected dogs were divided into three groups (10 animals each): group I (canine leishmaniosis), group II (canine ehrlichiosis) and group III (dogs co-infected by both infectious agents). Ten clinically healthy dogs were used as controls. A haematological profile was obtained and dog sera were assessed for the presence of platelet-bound IgM and IgG antibodies (PBIgM, PBIgG) using flow cytometry. Eight of the naturally co-infected dogs (80%), five of the leishmaniotic dogs (50%) and six of the ehrlichiotic dogs (60%) had detectable levels of platelet-bound antibodies (PBIg). No PBIg were observed in the control group. The hypothesis that Leishmania and Ehrlichia co-infection could more severely affect the immune response of infected dogs is discussed.
AuthorsLaura Cortese, Giuseppe Terrazzano, Diego Piantedosi, Michela Sica, Michele Prisco, Giuseppina Ruggiero, Paolo Ciaramella
JournalVeterinary journal (London, England : 1997) (Vet J) Vol. 188 Issue 1 Pg. 118-21 (Apr 2011) ISSN: 1532-2971 [Electronic] England
PMID20456989 (Publication Type: Journal Article)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Bacterial
  • Antibodies, Protozoan
  • Immunoglobulin G
  • Immunoglobulin M
Topics
  • Animals
  • Antibodies, Bacterial (blood, immunology)
  • Antibodies, Protozoan (blood, immunology)
  • Blood Platelets (immunology)
  • Dog Diseases (blood, immunology)
  • Dogs
  • Ehrlichia canis (immunology)
  • Ehrlichiosis (blood, immunology, veterinary)
  • Female
  • Flow Cytometry (veterinary)
  • Immunoglobulin G (blood, immunology)
  • Immunoglobulin M (blood, immunology)
  • Leishmania infantum (immunology)
  • Leishmaniasis, Visceral (blood, immunology, veterinary)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: